Page last updated: 2024-08-26

yttrium radioisotopes and Graft-Versus-Host Disease

yttrium radioisotopes has been researched along with Graft-Versus-Host Disease in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cassaday, RD; Flowers, ME; Gopal, AK; Green, DJ; Guthrie, KA; Maloney, DG; Pagel, JM; Press, OW; Rajendran, JG; Rezvani, AR; Sandmaier, BM; Sorror, ML; Storb, RF; Storer, BE	1
Bethge, WA; Bornhaeuser, M; Bunjes, D; Dittmann, H; Faul, C; Federmann, B; Kanz, L; Knop, S; Lange, T; Meisner, C; Stadler, M; Stelljes, M; Trenschel, R; Uharek, L; Vogel, W; von Harsdorf, S; Vucinic, V; Wulf, G	1
Blazar, BR; Buchsbaum, DJ; Everson, P; Schmidberger, H; Snover, DC; Vallera, DA	1

Trials

2 trial(s) available for yttrium radioisotopes and Graft-Versus-Host Disease

Article	Year
Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:2 Topics: Adult; Aged; Antibodies, Monoclonal; Antigens, CD20; Chronic Disease; Cohort Studies; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoma, Follicular; Male; Middle Aged; Myeloablative Agonists; Radioimmunotherapy; Survival Analysis; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation; Yttrium Radioisotopes	2015
Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study. Blood, 2010, Sep-09, Volume: 116, Issue:10 Topics: Adult; Aged; Antibodies, Monoclonal; Combined Modality Therapy; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radioimmunotherapy; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Yttrium Radioisotopes	2010

Article

Year

Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:2

Topics: Adult; Aged; Antibodies, Monoclonal; Antigens, CD20; Chronic Disease; Cohort Studies; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoma, Follicular; Male; Middle Aged; Myeloablative Agonists; Radioimmunotherapy; Survival Analysis; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation; Yttrium Radioisotopes

2015

Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study.

Blood, 2010, Sep-09, Volume: 116, Issue:10

Topics: Adult; Aged; Antibodies, Monoclonal; Combined Modality Therapy; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radioimmunotherapy; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Yttrium Radioisotopes

2010

Other Studies

1 other study(ies) available for yttrium radioisotopes and Graft-Versus-Host Disease

Article	Year
Radiotherapy in mice with yttrium-90-labeled anti-Ly1 monoclonal antibody: therapy of established graft-versus-host disease induced across the major histocompatibility barrier. Cancer research, 1991, Apr-01, Volume: 51, Issue:7 Topics: Animals; Antibodies, Monoclonal; Bone Marrow; Cause of Death; Female; Graft vs Host Disease; Isoantibodies; Leukocyte Count; Major Histocompatibility Complex; Mice; Mice, Inbred C57BL; Tumor Cells, Cultured; Yttrium Radioisotopes	1991

Article

Year

Radiotherapy in mice with yttrium-90-labeled anti-Ly1 monoclonal antibody: therapy of established graft-versus-host disease induced across the major histocompatibility barrier.

Cancer research, 1991, Apr-01, Volume: 51, Issue:7

Topics: Animals; Antibodies, Monoclonal; Bone Marrow; Cause of Death; Female; Graft vs Host Disease; Isoantibodies; Leukocyte Count; Major Histocompatibility Complex; Mice; Mice, Inbred C57BL; Tumor Cells, Cultured; Yttrium Radioisotopes

1991